Brucella Research Group, Statutory and Exotic Bacteria, Veterinary Laboratories Agency, Weybridge, New Haw, Addlestone, Surrey KT15 3NB, United Kingdom.
J Clin Microbiol. 2009 Oct;47(10):3098-107. doi: 10.1128/JCM.00919-09. Epub 2009 Aug 5.
Brucellosis is a globally significant zoonosis, the control of which is difficult and resource intensive. Serological tests form a vital part of a multifactorial approach to control and are often performed in large numbers. The aim of the present study was to develop a new assay to improve the efficiency, ease, and effectiveness of serological testing. An existing competitive enzyme-linked immunosorbent assay (cELISA) was adapted to a completely homogeneous time-resolved fluorescent resonance energy transfer (TR-FRET) assay. This was achieved by labeling an anti-Brucella monoclonal antibody with a long-lifetime donor fluorophore and Brucella smooth lipopolysaccharide with a compatible acceptor and optimizing the reading conditions. The assay was performed in a 96-well plate with a single 30-min incubation period and no separation (wash) steps and was concluded by a single plate-reading step. The performance of the assay was evaluated with a panel of serum samples from infected (n = 73) and uninfected (n = 480) sources and compared to the performance of the parent cELISA, an indirect ELISA (iELISA), and fluorescence polarization assay (FPA). The performance of the TR-FRET assay matched the performance of the iELISA, which had 100% diagnostic sensitivity and specificity, and surpassed the performance of the cELISA and the FPA. The results also demonstrated that the TR-FRET technique is effective with poor-quality serum samples from the field. To the knowledge of the authors, this is the first homogeneous TR-FRET assay to detect antibodies raised against an infectious disease. The technique appears to be sufficiently adaptable to meet the needs of many other similar testing requirements to identify infectious diseases.
布鲁氏菌病是一种具有全球重要意义的动物源性传染病,其控制难度大且资源密集。血清学检测是多因素控制策略的重要组成部分,通常需要进行大量检测。本研究旨在开发一种新的检测方法,以提高血清学检测的效率、简便性和有效性。我们对现有的竞争性酶联免疫吸附试验(cELISA)进行了改造,使其成为完全均相的时间分辨荧光共振能量转移(TR-FRET)检测方法。我们通过用长寿命供体荧光团标记抗布鲁氏菌单克隆抗体,并将布鲁氏菌光滑脂多糖标记为相容的受体来实现这一目标,同时优化了读取条件。该检测方法在 96 孔板中进行,单次孵育时间为 30 分钟,无需分离(洗涤)步骤,仅需进行单次板读数步骤。我们使用来自感染源(n = 73)和未感染源(n = 480)的血清样本对该检测方法进行了评估,并将其与原始 cELISA、间接酶联免疫吸附试验(iELISA)和荧光偏振检测(FPA)的性能进行了比较。该检测方法的性能与 iELISA 相当,具有 100%的诊断敏感性和特异性,优于 cELISA 和 FPA 的性能。结果还表明,该 TR-FRET 技术可有效检测来自现场的低质量血清样本。据作者所知,这是首次使用均相 TR-FRET 检测方法检测针对传染病产生的抗体。该技术似乎具有足够的适应性,能够满足许多其他类似检测要求,以识别传染病。